Real-World Comparison of Major Bleeding and Associated Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban or Warfarin

Amin, AlpeshKeshishian, AXie LBaşer, OnurPrice, KVo, LMardekian, JMendoza, MSinghal, SPatel, COdell, KTrocio, J2019-02-282019-02-282019-02-282019-02-282016Amin A, Keshishian A, Xie L, Baser O, Price K, Vo L, Mardekian J, Mendoza M, Singhal S, Patel C, Odell K, Trocio J. (August 27-31 , 2016). Real-world comparison of major bleeding and associated costs among treatment-naïve nonvalvular atrial fibrillation patients initiating apixaban or warfarin. European Society of Cardiology (ESC) Congress 2016. Rome, Italy.https://hdl.handle.net/20.500.11779/818Onur Başer (MEF Author)##nofulltext##...eninfo:eu-repo/semantics/closedAccessReal-World Comparison of Major Bleeding and Associated Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban or WarfarinConference Object